Literature DB >> 23239202

Recognizing global burden of cardiovascular disease and related chronic diseases.

Bridget B Kelly1, Jagat Narula, Valentín Fuster.   

Abstract

Cardiovascular disease is the leading cause of death worldwide, affecting not only high-income but also low- and middle-income countries. Nearly 80 percent of all estimated cardiovascular disease-related deaths worldwide now occur in low- and middle-income countries, where nearly 30 percent of all deaths are attributable to cardiovascular disease. The health burden of cardiovascular disease and other chronic diseases is also accompanied by a significant deleterious economic impact at the level of both national economies and households. The global trends in the health and economic burden of cardiovascular disease provide a compelling argument in support of prioritizing urgent yet carefully planned efforts to prevent and control cardiovascular disease worldwide-and especially in low- and middle-income countries. After decades of escalating efforts to draw attention to the high burden of cardiovascular disease and other chronic diseases, this critically important issue is now emerging as a more central part of the global health and development agenda. The breadth of behavioral, biological, social, environmental, and systems-level factors that contribute to cardiovascular disease necessitates multisectoral approaches across the lifecourse that promote healthful lifestyles, reduce risk, and reduce cardiovascular-disease morbidity and mortality through the delivery of quality health care services. Given that the complex interactions among the determinants of cardiovascular disease vary in different contexts, real progress in control efforts will come through approaches that are driven by a country's disease burden and risk profile, capacities, resources, and priorities-approaches that are led by a country's key decision-makers and stakeholders, including governments, civil society, the private sector, and communities. Many countries are already establishing efforts to address chronic diseases. In addition to these locally driven efforts, success will require active engagement and sustained action from a wide array of stakeholders operating at global and regional levels.
© 2012 Mount Sinai School of Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 23239202     DOI: 10.1002/msj.21345

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  32 in total

Review 1.  Stem cells: An eventual treatment option for heart diseases.

Authors:  Joseph C Bilgimol; Subbareddy Ragupathi; Lakshmanan Vengadassalapathy; Nathan S Senthil; Kalimuthu Selvakumar; M Ganesan; Sadananda Rao Manjunath
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

2.  Risk Factors and Plasma Glucose Profile of Gestational Diabetes in Omani Women.

Authors:  Havagiray R Chitme; Sumaiya Abdallah Said Al Shibli; Raya Mahmood Al-Shamiry
Journal:  Oman Med J       Date:  2016-09

3.  Cardiac surgery in Africa: a thirty-five year experience on open heart surgery in Cote d'Ivoire.

Authors:  Koffi Herve Yangni-Angate; Christophe Meneas; Florent Diby; Manga Diomande; Anicet Adoubi; Yves Tanauh
Journal:  Cardiovasc Diagn Ther       Date:  2016-10

4.  Bisphenol A alters autonomic tone and extracellular matrix structure and induces sex-specific effects on cardiovascular function in male and female CD-1 mice.

Authors:  Scott M Belcher; Robin B Gear; Eric L Kendig
Journal:  Endocrinology       Date:  2015-01-16       Impact factor: 4.736

5.  Fatiguing exercise initiated later in life reduces incidence of fibrillation and improves sleep quality in Drosophila.

Authors:  Lan Zheng; Yue Feng; Deng Tai Wen; Hui Wang; Xiu Shan Wu
Journal:  Age (Dordr)       Date:  2015-07-24

Review 6.  A systematic review of metabolite profiling in gestational diabetes mellitus.

Authors:  Jennifer Huynh; Grace Xiong; Rhonda Bentley-Lewis
Journal:  Diabetologia       Date:  2014-09-06       Impact factor: 10.122

7.  Perceived economic burden associated with an inherited cardiac condition: a qualitative inquiry with families affected by arrhythmogenic right ventricular cardiomyopathy.

Authors:  Holly Etchegary; Glenn Enright; Rick Audas; Daryl Pullman; Terry-Lynn Young; Kathy Hodgkinson
Journal:  Genet Med       Date:  2015-10-29       Impact factor: 8.822

8.  A Common Polymorphism of the Human Cardiac Sodium Channel Alpha Subunit (SCN5A) Gene Is Associated with Sudden Cardiac Death in Chronic Ischemic Heart Disease.

Authors:  Boglárka Marcsa; Réka Dénes; Krisztina Vörös; Gergely Rácz; Mária Sasvári-Székely; Zsolt Rónai; Klára Törő; Gergely Keszler
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 9.  Analytical Data Review to Determine the Factors Impacting Risk of Diabetes in North Al-Batinah Region, Oman.

Authors:  Jabar H Yousif; Firdouse R Khan; Kashif Zia; Nahad Al Saadi
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

10.  Plasma Cardiotrophin-1 as a Marker of Hypertension and Diabetes-Induced Target Organ Damage and Cardiovascular Risk.

Authors:  Luis Gamella-Pozuelo; Isabel Fuentes-Calvo; Manuel A Gómez-Marcos; José I Recio-Rodriguez; Cristina Agudo-Conde; José L Fernández-Martín; Jorge B Cannata-Andía; José M López-Novoa; Luis García-Ortiz; Carlos Martínez-Salgado
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.